
Avanos Medical AVNS
$ 24.55
68.96%
Annual report 2025
added 02-24-2026
Avanos Medical Interest Expense 2011-2026 | AVNS
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Avanos Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 3.3 M | 15.6 M | 15 M | 26.4 M | 31.6 M | 32.7 M | 33.1 M | 6 M | 100 K | 800 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 33.1 M | 100 K | 16.5 M |
Quarterly Interest Expense Avanos Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 3.1 M | - | 4.7 M | 3.5 M | 3.5 M | - | 3 M | 2.7 M | 1.3 M | - | 900 K | 900 K | 800 K | - | 4.3 M | 4.3 M | 4.3 M | - | 3.5 M | 3.5 M | 3.7 M | - | 4.2 M | 9.9 M | 8.8 M | - | 8.1 M | 7.8 M | 7.6 M | - | 8.4 M | 8.3 M | 8 M | - | 7.8 M | 8.9 M | 8.3 M | - | 100 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 9.9 M | 100 K | 4.97 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
7.68 M | $ 186.15 | 3.03 % | $ 13.9 B | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 11.57 | 2.84 % | $ 1.74 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
AxoGen
AXGN
|
167 K | $ 34.98 | 4.51 % | $ 1.61 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.33 | 0.15 % | $ 125 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.54 | 1.78 % | $ 1.69 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 292.47 | 1.49 % | $ 8.25 B | ||
|
Inogen
INGN
|
2.44 M | $ 6.45 | - | $ 172 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 40.21 | 2.97 % | $ 5.99 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 64.38 | 1.9 % | $ 95.3 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
LENSAR
LNSR
|
636 K | $ 5.98 | 1.01 % | $ 71.5 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 10.28 | 2.7 % | $ 291 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
78 K | $ 25.14 | 0.76 % | $ 213 M | ||
|
Myomo
MYO
|
-668 K | $ 0.75 | 3.23 % | $ 31.4 M | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.95 | 0.4 % | $ 8.18 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 95.0 | 2.17 % | $ 12.8 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.03 | - | $ 1.23 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.39 | 2.45 % | $ 929 M | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 116.53 | 2.8 % | $ 3.96 B | ||
|
Tandem Diabetes Care
TNDM
|
-13 M | $ 20.62 | 2.59 % | $ 1.4 B | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.45 | 2.95 % | $ 409 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.71 | 2.49 % | $ 384 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 55.0 | 0.15 % | $ 1.62 B |